The video exclusive features Leonard Calabrese, DO, discussing the top stories in the July issue of Healio Rheumatology. The focus is on chimeric antigen receptor T-cell therapy, with insights from experts like Georg Schett, MD, on its potential breakthrough in treating autoimmune diseases. Calabrese also highlights a feature on Mark Cuban’s Cost Plus Drug Company and discusses declining Medicare reimbursements. The July issue covers these topics and raises questions about the future of autoimmune disease treatment and the impact of innovative approaches in healthcare. Check out the full issue for more information.
Source link
CAR T-cell therapy ‘holding up as a possible breakthrough’ in autoimmune disease
